Experimental drug combination shows early effectiveness in advanced kidney cancer
MedicalXpress
|
Jun 05, 2026
An experimental drug combination may help overcome treatment resistance in advanced kidney cancer, according to early results from a first-in-human clinical trial led by Mayo Clinic researchers.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗